Kailera Therapeutics Raises $600 Million Series B to Advance Obesity Drug Pipeline
Kailera Therapeutics, a clinical-stage biopharmaceutical company focused on obesity treatments, has raised $600 million in a Series B financing round to accelerate development of its…
